Insider Trading activities at Teva Pharmaceutical Industries Ltd (TEVA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Teva Pharmaceutical Industries Ltd (TEVA) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Teva Pharmaceutical Industries Ltd. Table 2 shows the detailed insider transactions. This company's CIK number is 818686.

Total stock buying since 2018: $16,477,000.
Total stock sales since 2018: $69,039,464.
Total stock option exercises since 2018: $0.


 1   2   3 
38 insiders reported insider trading activities at Teva Pharmaceutical Industries Ltd (TEVA):
Insider trading activities of Schultz Kare
Insider trading activities of Shields Matthew
Insider trading activities of Lieberman Gerald M
Insider trading activities of Fridriksdottir Hafrun
Insider trading activities of Dethlefs Sven
Insider trading activities of Peres Nechemia Jacob
Insider trading activities of Mcavoy David R.
Insider trading activities of Vergis Janet S.
Insider trading activities of Nisen Perry
Insider trading activities of Shalev Varda
Insider trading activities of Barer Sol J
Insider trading activities of Elstein Amir
Insider trading activities of Halfon Jean Michel
Insider trading activities of Crane Rosemary A
Insider trading activities of Codner Iris Beck
Insider trading activities of Daniell Richard
Insider trading activities of Griffin Deborah A
Insider trading activities of De Notaristefani Carlo
Insider trading activities of Mcclellan Michael James
Insider trading activities of Stark David Matthew
Insider trading activities of Mignone Roberto
Insider trading activities of Kalif Eliyahu Sharon
Insider trading activities of Shani Eli
Insider trading activities of Sabag Mark
Insider trading activities of Nazzi Gianfranco
Insider trading activities of Jover Placid
Insider trading activities of Inbar Galia
Insider trading activities of Francis Richard D
Insider trading activities of Weiss Amir
Insider trading activities of Grant Angus
Insider trading activities of Zaks Tal Zvi
Insider trading activities of Satchi-fainaro Ronit
Insider trading activities of O'grady Brendan P.
Insider trading activities of Conway Vikki L
Insider trading activities of Fox Christine
Insider trading activities of Hughes Eric A
Insider trading activities of Drape Eric
Insider trading activities of Bergwerk Dov

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Teva Pharmaceutical Industries Ltd (TEVA).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 1,348,687 $22,334,919 1,392,330 $0
2024 0 $0 1,250,333 $19,421,105 857,819 $0
2023 0 $0 914,434 $8,878,064 1,922,885 $0
2022 0 $0 501,886 $4,166,032 1,423,472 $0
2021 0 $0 916,334 $10,354,171 1,059,530 $0
2020 0 $0 178,163 $2,199,069 884,416 $0
2019 215,500 $2,000,410 68,498 $958,892 194,325 $0
2018 752,000 $14,476,590 35,207 $727,212 59,029 $0

Table 2. Monthly summary of insider trading at Teva Pharmaceutical Industries Ltd (TEVA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-08 0 $0 58,795 $891,214 65,569 $0
2025-06 0 $0 61,981 $1,058,095 45,091 $0
2025-05 0 $0 337,915 $6,097,338 0 $0
2025-03 0 $0 581,114 $9,218,513 1,120,015 $0
2025-02 0 $0 308,882 $5,069,759 161,655 $0
2024-11 0 $0 19,388 $327,094 63,492 $0
2024-09 0 $0 0 $0 12,872 $0
2024-08 0 $0 172,605 $2,987,909 65,655 $0
2024-06 0 $0 519,000 $8,838,570 206,462 $0
2024-05 0 $0 43,354 $725,598 0 $0
2024-03 0 $0 184,649 $2,490,098 247,744 $0
2024-02 0 $0 311,337 $4,051,836 261,594 $0
2023-08 0 $0 89,848 $799,264 207,384 $0
2023-03 0 $0 221,661 $2,117,689 483,159 $0
2023-02 0 $0 602,925 $5,961,111 1,232,342 $0
2022-11 0 $0 0 $0 128,594 $0
2022-08 0 $0 55,500 $558,718 1,581 $0
2022-07 0 $0 58,163 $525,619 0 $0
2022-06 0 $0 0 $0 156,102 $0
2022-05 0 $0 130,000 $1,068,080 0 $0
2022-03 0 $0 170,531 $1,269,246 811,676 $0
2022-02 0 $0 87,692 $744,369 325,519 $0
2021-11 0 $0 0 $0 180,000 $0
2021-08 0 $0 50,860 $506,006 0 $0

Table 3. Detailed insider trading at Teva Pharmaceutical Industries Ltd (TEVA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-08-01 Jover Placid (See "Remarks") Sale 6,053 15.16 91,751
2025-08-01 Jover Placid (See "Remarks") Option Ex 12,827 .00 0
2025-08-01 Hughes Eric A (See "Remarks") Sale 52,742 15.16 799,463
2025-08-01 Hughes Eric A (See "Remarks") Option Ex 52,742 .00 0
2025-06-12 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Sale 55,775 17.08 952,469
2025-06-06 Shalev Varda Option Ex 9,632 .00 0
2025-06-06 Zaks Tal Zvi Option Ex 9,632 .00 0
2025-06-06 Mignone Roberto Option Ex 9,632 .00 0
2025-06-03 Shields Matthew (EVP, Global Operations) Sale 6,206 17.02 105,626
2025-06-03 Shields Matthew (EVP, Global Operations) Option Ex 16,195 .00 0
2025-05-08 Sabag Mark (See "Remarks") Sale 337,915 18.04 6,097,338
2025-03-05 Fox Christine (EVP, Head of U.S. Commercial) Sale 2,147 15.91 34,165
2025-03-05 Hughes Eric A (See "Remarks") Sale 8,077 15.91 128,529
2025-03-05 Weiss Amir (Chief Accounting Officer) Option Ex 3,566 .00 0
2025-03-05 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Option Ex 21,390 .00 0
2025-03-05 Mcavoy David R. (EVP, Chief Legal Officer) Sale 1,677 15.91 26,686
2025-03-05 Daniell Richard (Exec. VP, European Commercial) Sale 119,725 15.91 1,904,757
2025-03-05 Daniell Richard (Exec. VP, European Commercial) Option Ex 22,576 .00 0
2025-03-05 Sabag Mark (See "Remarks") Option Ex 23,765 .00 0
2025-03-05 Francis Richard D (President and CEO) Sale 8,259 15.91 131,425
2025-03-04 Fox Christine (EVP, Head of U.S. Commercial) Sale 4,034 15.73 63,474
2025-03-04 Fox Christine (EVP, Head of U.S. Commercial) Option Ex 20,461 .00 0
2025-03-04 Hughes Eric A (See "Remarks") Sale 20,348 15.65 319,259
2025-03-04 Hughes Eric A (See "Remarks") Option Ex 23,251 .00 0
2025-03-04 Weiss Amir (Chief Accounting Officer) Option Ex 16,326 .00 0
2025-03-04 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Option Ex 239,932 .00 0
2025-03-04 Mcavoy David R. (EVP, Chief Legal Officer) Sale 3,150 15.73 49,565
2025-03-04 Mcavoy David R. (EVP, Chief Legal Officer) Option Ex 16,741 .00 0
2025-03-04 Daniell Richard (Exec. VP, European Commercial) Sale 104,544 15.65 1,642,709
2025-03-04 Daniell Richard (Exec. VP, European Commercial) Option Ex 237,142 .00 0
2025-03-04 Sabag Mark (See "Remarks") Option Ex 235,282 .00 0
2025-03-04 Francis Richard D (President and CEO) Sale 21,964 15.65 344,461
2025-03-04 Francis Richard D (President and CEO) Option Ex 50,223 .00 0
2025-03-03 Hughes Eric A (See "Remarks") Sale 19,726 16.19 319,285
2025-03-03 Hughes Eric A (See "Remarks") Option Ex 24,900 .00 0
2025-03-03 Weiss Amir (Chief Accounting Officer) Option Ex 5,179 .00 0
2025-03-03 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Option Ex 49,800 .00 0
2025-03-03 Daniell Richard (Exec. VP, European Commercial) Sale 49,314 16.19 798,196
2025-03-03 Daniell Richard (Exec. VP, European Commercial) Option Ex 62,250 .00 0
2025-03-03 Francis Richard D (President and CEO) Sale 24,892 16.19 402,901
2025-03-03 Francis Richard D (President and CEO) Option Ex 67,231 .00 0
2025-02-28 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Sale 55,750 16.21 903,484
2025-02-18 Francis Richard D (President and CEO) Sale 75,506 16.95 1,279,675
2025-02-15 Francis Richard D (President and CEO) Option Ex 161,655 .00 0
2025-02-12 Sabag Mark (See "Remarks") Sale 177,626 16.25 2,886,600
2024-11-20 Fox Christine (EVP, Head of U.S. Commercial) Sale 19,388 16.87 327,094
2024-11-20 Fox Christine (EVP, Head of U.S. Commercial) Option Ex 63,492 .00 0
2024-09-02 Shalev Varda Option Ex 12,872 .00 0
2024-08-12 Daniell Richard (Exec. VP, European Commercial) Sale 98,943 17.30 1,711,417
2024-08-09 Grant Angus (EVP, Business Development) Sale 4,065 17.28 70,243
2024-08-09 Grant Angus (EVP, Business Development) Option Ex 12,913 .00 0
2024-08-09 Hughes Eric A (See "Remarks") Sale 45,060 17.38 782,962
2024-08-01 Hughes Eric A (See "Remarks") Sale 24,537 17.25 423,287
2024-08-01 Hughes Eric A (See "Remarks") Option Ex 52,742 .00 0
2024-06-18 Mignone Roberto Sale 519,000 17.03 8,838,570
2024-06-15 Satchi-fainaro Ronit Option Ex 21,108 .00 0
2024-06-15 Elstein Amir Option Ex 21,108 .00 0
2024-06-15 Zaks Tal Zvi Option Ex 21,108 .00 0
2024-06-15 Nisen Perry Option Ex 21,108 .00 0
2024-06-15 Vergis Janet S. Option Ex 21,108 .00 0
2024-06-15 Crane Rosemary A Option Ex 21,108 .00 0
2024-06-15 Mignone Roberto Option Ex 21,108 .00 0
2024-06-15 Barer Sol J Option Ex 37,598 .00 0
2024-06-15 Lieberman Gerald M Option Ex 21,108 .00 0
2024-05-16 Weiss Amir (Chief Accounting Officer) Sale 12,635 16.65 210,372
2024-05-15 Weiss Amir (Chief Accounting Officer) Sale 15,500 16.80 260,415
2024-05-13 Conway Vikki L (See "Remarks") Sale 15,219 16.74 254,811
2024-03-05 Conway Vikki L (See "Remarks") Sale 1,427 13.52 19,285
2024-03-05 Conway Vikki L (See "Remarks") Option Ex 4,954 .00 0
2024-03-05 Weiss Amir (Chief Accounting Officer) Option Ex 3,564 .00 0
2024-03-05 Daniell Richard (Exec. VP, European Commercial) Sale 48,629 13.52 657,220
2024-03-05 Daniell Richard (Exec. VP, European Commercial) Option Ex 77,802 .00 0
2024-03-05 Sabag Mark (EVP, International Markets) Sale 100,000 13.52 1,352,100
2024-03-05 Sabag Mark (EVP, International Markets) Option Ex 81,897 .00 0
2024-03-04 Conway Vikki L (See "Remarks") Sale 3,532 13.37 47,233
2024-03-04 Conway Vikki L (See "Remarks") Option Ex 7,117 .00 0
2024-03-04 Francis Richard D (President and CEO) Sale 31,061 13.34 414,260
2024-03-03 Conway Vikki L (See "Remarks") Option Ex 5,179 .00 0
2024-03-03 Francis Richard D (President and CEO) Option Ex 67,231 .00 0
2024-02-28 Bergwerk Dov (Acting Chief Legal Officer) Option Ex 6,653 .00 0
2024-02-28 Conway Vikki L (See "Remarks") Sale 1,366 13.12 17,916
2024-02-28 Conway Vikki L (See "Remarks") Option Ex 4,294 .00 0
2024-02-28 Weiss Amir (Chief Accounting Officer) Option Ex 3,219 .00 0
2024-02-28 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Option Ex 18,430 .00 0
2024-02-28 Drape Eric (Executive VP Global Operations) Sale 9,815 13.12 128,733
2024-02-28 Drape Eric (Executive VP Global Operations) Option Ex 19,515 .00 0
2024-02-28 Daniell Richard (Exec. VP, European Commercial) Sale 20,599 13.12 270,176
2024-02-28 Daniell Richard (Exec. VP, European Commercial) Option Ex 20,599 .00 0
2024-02-28 Sabag Mark (EVP, International Markets) Option Ex 20,599 .00 0
2024-02-16 Drape Eric (Executive VP Global Operations) Sale 173,261 13.05 2,261,922
2024-02-15 Francis Richard D (President and CEO) Sale 74,530 13.15 980,144
2024-02-15 Francis Richard D (President and CEO) Option Ex 161,655 .00 0
2024-02-13 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Option Ex 6,630 .00 0
2024-02-01 Weiss Amir (Chief Accounting Officer) Sale 31,766 12.37 392,945
2023-08-07 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Sale 35,125 9.73 341,906
2023-08-04 Weiss Amir (Chief Accounting Officer) Sale 1,981 9.92 19,653
2023-08-04 Satchi-fainaro Ronit (Director) Option Ex 15,810 .00 0
2023-08-04 Elstein Amir (Director) Option Ex 15,810 .00 0
2023-08-04 Zaks Tal Zvi (Director) Option Ex 15,810 .00 0
2023-08-04 Nisen Perry (Director) Option Ex 15,810 .00 0
2023-08-04 Vergis Janet S. (Director) Option Ex 15,810 .00 0
2023-08-04 Crane Rosemary A (Director) Option Ex 15,810 .00 0
2023-08-04 Mignone Roberto (Director) Option Ex 15,810 .00 0
2023-08-04 Barer Sol J (Director) Option Ex 28,162 .00 0
2023-08-04 Lieberman Gerald M (Director) Option Ex 15,810 .00 0
2023-08-01 Hughes Eric A (See "Remarks") Sale 52,742 8.30 437,705
2023-08-01 Hughes Eric A (See "Remarks") Option Ex 52,742 .00 0
2023-03-07 Drape Eric (Executive VP Global Operations) Sale 4,699 9.43 44,302
2023-03-07 Daniell Richard (Exec. VP, European Commercial) Sale 54,007 9.43 509,177
2023-03-07 Dethlefs Sven (EVP, North America Commercial) Sale 58,066 9.43 547,446
2023-03-07 Stark David Matthew (Exec. VP Chief Legal Officer) Sale 49,475 9.43 466,450
2023-03-06 Drape Eric (Executive VP Global Operations) Sale 1,566 9.93 15,551
2023-03-06 Daniell Richard (Exec. VP, European Commercial) Sale 18,002 9.93 178,777
2023-03-06 Dethlefs Sven (EVP, North America Commercial) Sale 19,355 9.93 192,214
2023-03-06 Stark David Matthew (Exec. VP Chief Legal Officer) Sale 16,491 9.93 163,772
2023-03-05 Weiss Amir (Chief Accounting Officer) Option Ex 3,564 .00 0
2023-03-05 Inbar Galia (See "Remarks") Option Ex 5,710 .00 0
2023-03-05 Shani Eli (EVP,Global Marketing&Portfolio) Option Ex 5,896 .00 0
2023-03-05 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Option Ex 21,387 .00 0
2023-03-05 Drape Eric (Executive VP Global Operations) Option Ex 22,576 .00 0
2023-03-05 Daniell Richard (Exec. VP, European Commercial) Option Ex 22,576 .00 0
2023-03-05 Dethlefs Sven (EVP, North America Commercial) Option Ex 24,952 .00 0
2023-03-05 Stark David Matthew (Exec. VP Chief Legal Officer) Option Ex 20,199 .00 0
2023-03-05 Sabag Mark (EVP, International Markets) Option Ex 23,764 .00 0
2023-03-04 Weiss Amir (Chief Accounting Officer) Option Ex 13,082 .00 0
2023-03-04 Inbar Galia (See "Remarks") Option Ex 20,107 .00 0
2023-03-04 Shani Eli (EVP,Global Marketing&Portfolio) Option Ex 23,280 .00 0
2023-03-04 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Option Ex 33,512 .00 0
2023-03-04 Drape Eric (Executive VP Global Operations) Option Ex 45,452 .00 0
2023-03-04 Daniell Richard (Exec. VP, European Commercial) Option Ex 49,433 .00 0
2023-03-04 Dethlefs Sven (EVP, North America Commercial) Option Ex 52,469 .00 0
2023-03-04 Stark David Matthew (Exec. VP Chief Legal Officer) Option Ex 45,767 .00 0
2023-03-04 Sabag Mark (EVP, International Markets) Option Ex 49,433 .00 0
2023-02-28 Weiss Amir (Chief Accounting Officer) Option Ex 6,438 .00 0
2023-02-28 Inbar Galia (See "Remarks") Option Ex 9,656 .00 0
2023-02-28 Shani Eli (EVP,Global Marketing&Portfolio) Option Ex 10,622 .00 0
2023-02-28 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Option Ex 126,766 .00 0
2023-02-28 Drape Eric (Executive VP Global Operations) Sale 67,370 9.89 666,086
2023-02-28 Drape Eric (Executive VP Global Operations) Option Ex 134,224 .00 0
2023-02-28 Daniell Richard (Exec. VP, European Commercial) Sale 88,504 9.89 875,038
2023-02-28 Daniell Richard (Exec. VP, European Commercial) Option Ex 141,680 .00 0
2023-02-28 Dethlefs Sven (EVP, North America Commercial) Sale 119,310 9.89 1,179,616
2023-02-28 Dethlefs Sven (EVP, North America Commercial) Option Ex 119,310 .00 0
2023-02-28 Stark David Matthew (Exec. VP Chief Legal Officer) Sale 126,766 9.89 1,253,334
2023-02-28 Stark David Matthew (Exec. VP Chief Legal Officer) Option Ex 126,766 .00 0
2023-02-28 Sabag Mark (EVP, International Markets) Option Ex 141,680 .00 0
2023-02-13 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Option Ex 6,629 .00 0
2022-11-04 Zaks Tal Zvi (Director) Option Ex 12,205 .00 0
2022-11-01 Schultz Kare (President and CEO) Option Ex 116,389 .00 0
2022-08-22 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Sale 55,500 10.07 558,718
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of TEVA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Teva Pharmaceutical Industries Ltd (symbol TEVA, CIK number 818686) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.